Navigation Links
Before the Bell Scans: Pharmacyclics, United Therapeutics, Impax Laboratories, and Star Scientific
Date:6/24/2013

LONDON, June 24, 2013 /PRNewswire/ --

On Friday, June 21, 2013, shares in drug manufacturers ended on a mixed note, tracking the broader market which also finished mixed after witnessing losses in two successive trading sessions. The major movers included Pharmacyclics Inc. (NASDAQ: PCYC), United Therapeutics Corporation (NASDAQ: UTHR), Impax Laboratories Inc. (NASDAQ: IPXL), and Star Scientific Inc. (NASDAQ: STSI). All these companies are tracked by AAAResearchReports.com. Free technical research on PCYC, UTHR, IPXL, and STSI can be downloaded upon sign up at

http://www.aaaresearchreports.com/register/  

Shares in Pharmacyclics Inc. ended slightly lower on Friday, extending their losses from previous trading sessions. The company's shares oscillated between $78.23 and $81.96 before closing the day at $81.00, down 0.36%. A total of 1.05 million shares were traded which is above the daily average volume of 739,954. Pharmacyclics' shares have now declined by over 8.20% in the last three sessions. Sign up today to read free research report on PCYC at:

http://www.AAAResearchReports.com/PCYC062413.pdf

United Therapeutics Corporation's stock posted modest gains on Friday, reversing some of its losses from previous market sessions. The company's shares ended the day at $63.34, up 0.19%, after trading between $62.78 and $64.55. A total of 818,292 shares were traded which is above the daily average volume of 567,754. United Therapeutics' shares have slipped by more than 3.50% in the last three trading sessions. However, despite the recent losses, the stock is still up 3.92% in the last three months. Register to download free technical analysis on UTHR at:

http://www.AAAResearchReports.com/UTHR062413.pdf

Shares in Impax Laboratories Inc. moved higher on Friday, paring some of its losses from its previous two trading sessions. The company's shares traded between $17.69 and $18.22 before finishing the day 0.72% higher at $18.09. A total of 1.54 million shares were traded which is above the daily average volume of 1.15 million. Impax's shares have now fallen more than 4% in the last three sessions. In the last three months, the stock has gained over 15.80%, thus outperforming the S&P 500. Additionally, shares of the company are currently trading slightly above their 50-day moving average. A free report on IPXL can be accessed by registering at:

http://www.AAAResearchReports.com/IPXL062413.pdf

Star Scientific Inc.'s stock rose sharply on Friday, closing 1.53% higher at $1.33 after trading between $1.24 and $1.33. A total of 1.73 million shares were traded which is above the daily average volume of 1.07 million. However, despite the sharp rise on Friday, the company's shares have fallen by 8.28% in the last three trading sessions. Moreover, the stock is also trading above its 50-day and 200-day moving average. Register with AAA Research Reports and download the research on STSI for free at:

http://www.AAAResearchReports.com/STSI062413.pdf

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


'/>"/>
SOURCE AAA Research Reports
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. United Therapeutics Corporation to Announce Second Quarter 2012 Financial Results Before Market Open on Thursday, July 26, 2012
2. United Therapeutics Corporation To Announce Third Quarter 2012 Financial Results Before Market Open On Thursday, November 1, 2012
3. Wysebridge Encourages Taking The Patent Bar Before Major Exam Changes Are Implemented
4. United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013
5. United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
6. A Simple Guide to De-Risking Before Full Prescribing Information, New Life Science Webinar Hosted by Xtalks
7. Grab the Summer Promo Before It Cools Down by Conscires Agile Practices
8. Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCalls Microscope
9. Animal Husbandry Equipment Market in United States: Business Report 2011
10. Strategic Analysis of the Collagen Peptide Market in the United States
11. GDS International Combines Top Healthcare Executives in the United States for its 10th Anniversary NG Healthcare Summit in May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 07, 2016 , ... A new study published in the ... treated, advanced pancreatic cancer, liquid biopsies are not yet an adequate substitute for ... blood sampling may improve the value of a blood-based test.” The study was ...
(Date:12/7/2016)... 2016 Neogen Corporation (NASDAQ: NEOG ... Kephart as its chief science officer — a ... responsibilities at Neogen effective Jan. 1. Kephart ... agribusiness unit of Thermo Fisher Scientific, as well as ... His extensive industry experience also includes the management of ...
(Date:12/7/2016)... , Dec. 7, 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" ... that will be presented at the Company,s Annual and Special ... of Shareholders will take place on Thursday, December 15, 2016 ... Glenn Hall (Room EC1040), 4825 Mount Royal Gate SW, ... (MST). A notice of meeting and management information circular, containing ...
(Date:12/7/2016)... Dec. 7, 2016  Biocom, the association for the ... below following passage of 21 st Century Cures legislation ... 30 by a 392-26 vote and in the Senate on ... attributed to Joe Panetta , president & CEO of ... give hope to millions of patients around the world. The ...
Breaking Biology Technology:
(Date:11/24/2016)... 2016 Cercacor today introduced Ember TM ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, ... Rate in approximately 30 seconds. Smaller than a smartphone, ... access to key data about their bodies to help ... Hemoglobin carries oxygen to muscles. When ...
(Date:11/22/2016)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the company has ... Sciences Awards as "Most Outstanding in eClinical Solutions" ... of recognition and growth for MedNet, which has effectively ... iMedNet ™ , MedNet,s flagship eClinical ...
(Date:11/19/2016)... 18, 2016 Securus Technologies, a leading provider ... safety, investigation, corrections and monitoring, announced today that it ... to have an independent technology judge determine who has ... high tech/sophisticated telephone calling platform, and the best customer ... do most of what we do – which clearly ...
Breaking Biology News(10 mins):